Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

Cortés, J, Rugo, HS, Awada, A et al. (16 more authors) (2017) Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial. Breast Cancer Research and Treatment, 165 (2). pp. 329-341. ISSN 0167-6806

Abstract

Metadata

Authors/Creators:
  • Cortés, J
  • Rugo, HS
  • Awada, A
  • Twelves, C
  • Perez, EA
  • Im, SA
  • Gómez-Pardo, P
  • Schwartzberg, LS
  • Diéras, V
  • Yardley, DA
  • Potter, DA
  • Mailliez, A
  • Moreno-Aspitia, A
  • Ahn, J-S
  • Zhao, C
  • Hoch, U
  • Tagliaferri, M
  • Hannah, AL
  • O’Shaughnessy, J
Copyright, Publisher and Additional Information: © 2017, The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Brain metastases; Etirinotecan pegol; NKTR-102; Chemotherapy; Metastatic breast cancer
Dates:
  • Published: September 2017
  • Accepted: 16 May 2017
  • Published (online): 13 June 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Jan 2019 15:55
Last Modified: 11 Jul 2019 16:04
Status: Published
Publisher: Springer Nature
Identification Number: https://doi.org/10.1007/s10549-017-4304-7
Related URLs:

Commentary/Response Threads

Share / Export

Statistics